Development
Ultralife Corporation
ULBI
$7.70
-$0.155-1.98%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 25.70% | 33.26% | 29.92% | 34.17% | 15.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.70% | 33.26% | 29.92% | 34.17% | 15.48% |
| Cost of Revenue | 23.24% | 34.05% | 32.83% | 39.37% | 20.83% |
| Gross Profit | 34.23% | 30.64% | 20.75% | 18.73% | 0.09% |
| SG&A Expenses | 5.74% | 10.65% | 15.99% | 22.86% | 17.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.15% | 28.23% | 27.80% | 33.94% | 19.15% |
| Operating Income | 910.21% | 496.23% | 266.76% | 78.04% | -133.97% |
| Income Before Tax | 500.28% | 291.41% | 65.59% | -195.36% | -135.24% |
| Income Tax Expenses | 501.31% | 313.49% | 46.53% | -512.66% | -139.30% |
| Earnings from Continuing Operations | 499.90% | 283.96% | 72.52% | 47.83% | -133.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 400.00% | -225.00% | 0.00% | 125.00% | 70.00% |
| Net Income | 499.61% | 284.48% | 72.32% | 49.15% | -134.14% |
| EBIT | 910.21% | 496.23% | 266.76% | 78.04% | -133.97% |
| EBITDA | 208.95% | 172.58% | 80.11% | 32.55% | -40.15% |
| EPS Basic | 497.34% | 283.61% | 72.33% | 47.52% | -133.86% |
| Normalized Basic EPS | 781.59% | 415.15% | 127.49% | 0.78% | -139.01% |
| EPS Diluted | 474.24% | 265.97% | 62.99% | 25.49% | -136.00% |
| Normalized Diluted EPS | 780.77% | 415.15% | 127.06% | 9.32% | -139.65% |
| Average Basic Shares Outstanding | 0.31% | 0.25% | 0.41% | 0.56% | 0.71% |
| Average Diluted Shares Outstanding | 0.38% | 0.23% | 0.06% | -0.06% | -0.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |